Cheng Tian
Shanghai University(CN)Northwestern Polytechnical University(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Shandong Tumor Hospital(CN)The Affiliated Yongchuan Hospital of Chongqing Medical University(CN)University of Hong Kong - Shenzhen Hospital(CN)China State Construction Engineering (China)(CN)Tongji Hospital(CN)Shandong First Medical University(CN)Institute of Pharmacology(CZ)University of Bergen(NO)Huazhong University of Science and Technology(CN)Chongqing Medical University(CN)University of Hong Kong(HK)
Publications by Year
Research Areas
COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Cancer Immunotherapy and Biomarkers, Liver Disease Diagnosis and Treatment, Neuroscience and Neuropharmacology Research
Most-Cited Works
- → Clinical Features of COVID-19-Related Liver Functional Abnormality(2020)848 cited
- → Clinical Features of COVID-19-Related Liver Damage(2020)165 cited
- → Mitochondrial Ca2+ uptake by the voltage-dependent anion channel 2 regulates cardiac rhythmicity(2015)86 cited
- → Kinsenoside attenuates liver fibro-inflammation by suppressing dendritic cells via the PI3K-AKT-FoxO1 pathway(2022)83 cited
- → SIRT1: Harnessing multiple pathways to hinder NAFLD(2024)51 cited
- → Ginsenoside Rh2 reverses cyclophosphamide-induced immune deficiency by regulating fatty acid metabolism(2019)44 cited